Replies to post #182386 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

Federico Goodsaid,3Harald Hampel,1
Mohammad Afshar2, Frédéric Parmentier2,
Coralie Williams2, Adrien Etcheto2,
Christopher U Missling4
1Department of Neurology, Sorbonne
University, Paris, France, 2Ariana Pharma,
Paris, France, 3Regulatory Pathfnders LLC,
San Francisco, CA, 4Anavex Life Sciences
Corp., New York, NY
“Longitudinal 148-Week Extension Study for
ANAVEX®2-73 Phase 2a Alzheimer’s Disease
Demonstrates Maintained Activities of Daily
Living Score (ADCS-ADL) and Reduced
Cognitive Decline (MMSE) for Patient Cohort
on Higher Drug Concentration and Confrms
Role of Patient Selection Biomarkers

Thanks drv17, we note that no one else can now make these claims w/o being challenged by a law suit.